Acrivon Therapeutics annual depreciation and amortization
2021
2022
2023
2024
2025
Acrivon Therapeutics Depreciation & Amortization Growth & History (ACRV)
Acrivon Therapeutics's depreciation and amortization was $1.4M for fiscal 2025.
View full Acrivon Therapeutics company overviewAcrivon Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.4M | $350,000 | +34.79% |
| 2024 | 2024-12-31 | $1.0M | $470,000 | +87.69% |
| 2023 | 2023-12-31 | $536,000 | $172,000 | +47.25% |
| 2022 | 2022-12-31 | $364,000 | $327,000 | +883.78% |
| 2021 | 2021-12-31 | $37,000 | — | — |
Acrivon Therapeutics quarterly depreciation and amortization
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $400,000 | $100,000 | +33.33% |
| Q1 2026 | 2026-03-31 | $383,000 | $72,000 | +23.15% |
| Q4 2025 | 2025-12-31 | $361,000 | — | — |
| Q3 2025 | 2025-09-30 | $300,000 | $0 | 0.00% |
| Q2 2025 | 2025-06-30 | $300,000 | $100,000 | +50.00% |
| Q1 2025 | 2025-03-31 | $311,000 | $87,000 | +38.84% |
| Q3 2024 | 2024-09-30 | $300,000 | $200,000 | +200.00% |
| Q2 2024 | 2024-06-30 | $200,000 | $100,000 | +100.00% |
| Q1 2024 | 2024-03-31 | $224,000 | $99,000 | +79.20% |
| Q3 2023 | 2023-09-30 | $100,000 | $0 | 0.00% |
| Q2 2023 | 2023-06-30 | $100,000 | $0 | 0.00% |
| Q1 2023 | 2023-03-31 | $125,000 | $80,000 | +177.78% |
| Q3 2022 | 2022-09-30 | $100,000 | $91,000 | +1011.11% |
| Q2 2022 | 2022-06-30 | $100,000 | — | — |
| Q1 2022 | 2022-03-31 | $45,000 | — | — |
| Q3 2021 | 2021-09-30 | $9,000 | — | — |
Acrivon Therapeutics depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Acrivon Therapeutics's depreciation and amortization increased from $37,000 to $1.4M, a change of $1.3M. The latest reported quarter, Q2 2026, shows $400,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acrivon Therapeutics source filings ↗